| Literature DB >> 26876167 |
Liat Buzaglo-Azriel1, Yael Kuperman2, Michael Tsoory2, Yehudit Zaltsman1, Liat Shachnai1, Smadar Levin Zaidman3, Elad Bassat1, Inbal Michailovici1, Alona Sarver1, Eldad Tzahor1, Michal Haran4, Cecile Vernochet5, Atan Gross6.
Abstract
Mitochondrial carrier homolog 2 (MTCH2) is a repressor of mitochondrial oxidative phosphorylation (OXPHOS), and its locus is associated with increased BMI in humans. Here, we demonstrate that mice deficient in muscle MTCH2 are protected from diet-induced obesity and hyperinsulinemia and that they demonstrate increased energy expenditure. Deletion of muscle MTCH2 also increases mitochondrial OXPHOS and mass, triggers conversion from glycolytic to oxidative fibers, increases capacity for endurance exercise, and increases heart function. Moreover, metabolic profiling of mice deficient in muscle MTCH2 reveals a preference for carbohydrate utilization and an increase in mitochondria and glycolytic flux in muscles. Thus, MTCH2 is a critical player in muscle biology, modulating metabolism and mitochondria mass as well as impacting whole-body energy homeostasis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26876167 DOI: 10.1016/j.celrep.2016.01.046
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423